# Red Cell Transfusion Thresholds

Use a restrictive hemoglobin threshold for most hemodynamically stable hospitalized adults, but distinguish acute myocardial infarction, cardiac surgery, orthopedic surgery, and preexisting cardiovascular disease, where trial populations and current recommendations support different decision thresholds.

**Clinical question:** Which hemoglobin thresholds should guide red blood cell transfusion in hospitalized adults across major clinical settings?

Updated: 2026-09-15T18:24:42.652006+00:00

## What matters in practice
- For hemodynamically stable hospitalized adults, consider RBC transfusion when hemoglobin is less than 7 g/dL; this is a strong AABB recommendation supported by moderate-certainty evidence. [23][24]
- A threshold of 7.5 g/dL is a reasonable restrictive strategy for cardiac surgery, while 8 g/dL may be selected for orthopedic surgery or preexisting cardiovascular disease. [23]
- In hospitalized patients with acute myocardial infarction and anemia, AABB suggests a liberal strategy when hemoglobin is less than 10 g/dL; the recommendation is conditional and based on low-certainty evidence. [9]
- The 2025 ACS guideline states that transfusion to maintain hemoglobin at 10 g/dL may be reasonable in acute or chronic anemia when the patient is not actively bleeding. [2]
- Do not apply the general stable-adult 7 g/dL threshold automatically to acute coronary syndrome, chronic transfusion-dependent anemia, or patients with severe thrombocytopenia related to hematologic or oncologic treatment. [24]

## Choose the threshold from the clinical setting before ordering red cells

Use hemoglobin with the current syndrome, not hemoglobin alone.

For a hemodynamically stable hospitalized adult without acute myocardial infarction, cardiac surgery, orthopedic surgery, or a specifically higher-risk cardiovascular context, use a restrictive approach and consider RBC transfusion when hemoglobin is less than 7 g/dL. The 2023 AABB guideline gives this a strong recommendation with moderate-certainty evidence. [23]

A threshold is a trigger for clinical reassessment, not an automatic order. AABB good-practice guidance directs clinicians to integrate hemoglobin concentration with the overall clinical context, patient preferences, and alternatives to transfusion. [24] In practice, first determine whether the patient belongs to an exception population, has ongoing blood loss, or has myocardial ischemia that changes the threshold strategy.

The evidence base for restrictive practice is broad: 45 randomized trials involving 20,599 adults compared restrictive thresholds, usually 7 to 8 g/dL, with liberal thresholds of 9 to 10 g/dL. For most populations, restrictive thresholds did not adversely affect patient-important outcomes. [23]
- Hemodynamically stable adult without a major exception: consider transfusion at hemoglobin less than 7 g/dL. [23]
- Cardiac surgery: use a restrictive threshold of 7.5 g/dL when applying the 2023 AABB framework. [23]
- Orthopedic surgery or preexisting cardiovascular disease: a threshold of 8 g/dL may be selected. [23]
- Acute myocardial infarction: do not default to 7 or 8 g/dL; consider the AMI-specific liberal strategy. [9]

*Hemoglobin-based RBC transfusion thresholds should be selected by the active clinical context. [2][9][23][24]*

| Hospitalized adult population | Hemoglobin decision threshold | Clinical application |
| --- | --- | --- |
| Hemodynamically stable adult | Consider transfusion at <7 g/dL [23] | Strong AABB recommendation; moderate-certainty evidence. [23] |
| Cardiac surgery | 7.5 g/dL may be used [23] | Restrictive strategy favored over 9.0-9.5 g/dL liberal strategies in current cardiac-surgery guidance. [7] |
| Orthopedic surgery | 8 g/dL may be used [23] | Use a setting-specific restrictive threshold rather than a universal 7 g/dL trigger. [23] |
| Preexisting cardiovascular disease | 8 g/dL may be used [23] | Different from acute coronary syndrome or acute MI, where evidence and recommendations have evolved separately. [9][24] |
| Acute myocardial infarction | Liberal strategy when <10 g/dL is suggested [9] | Conditional, low-certainty AABB recommendation; 2025 ACS guidance states maintaining 10 g/dL may be reasonable when not actively bleeding. [2][9] |

## Use the 7 g/dL threshold for most stable hospitalized adults

This is the default strategy, not a universal rule.

For hospitalized adults who are hemodynamically stable, including critically ill adults, the recommended restrictive threshold is hemoglobin less than 7 g/dL rather than 10 g/dL. [23][24] This approach should anchor routine inpatient transfusion decisions unless a condition-specific threshold applies.

A restrictive threshold reduces exposure to RBC transfusion without worse patient-important outcomes in most studied populations. [23] In a systematic review of 26 trials enrolling 15,681 patients, 30-day mortality did not differ between restrictive and liberal strategies, with a risk ratio of 1.0 and 95% confidence interval of 0.86 to 1.16. [21]

Do not use the general stable-adult recommendation as a substitute for identifying populations excluded from or insufficiently addressed by that framework. The 2016 AABB guideline specifically stated that its recommendations did not apply to acute coronary syndrome, severe thrombocytopenia in hematologic or oncologic patients at bleeding risk, or chronic transfusion-dependent anemia. [24]
- If hemoglobin is at least 7 g/dL and the patient is stable, do not transfuse solely to achieve a conventional hemoglobin target of 9 to 10 g/dL. [23][24]
- If hemoglobin is less than 7 g/dL, consider RBC transfusion while reassessing the indication in the context of the active illness and alternatives to transfusion. [23][24]
- If the patient has acute MI, recent or planned cardiac surgery, orthopedic surgery, or preexisting cardiovascular disease, move to the relevant threshold branch rather than applying the default threshold. [23]

## Use an acute MI-specific strategy when anemia coexists with infarction

Acute MI is the principal exception to a routine restrictive threshold.

For hospitalized patients with acute myocardial infarction, AABB suggests a liberal RBC transfusion strategy when hemoglobin is less than 10 g/dL. This is a conditional recommendation based on low-certainty evidence, so the decision should remain individualized rather than protocolized as an unconditional target. [9]

The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline states that RBC transfusion to maintain hemoglobin at 10 g/dL may be reasonable for patients with ACS and acute or chronic anemia who are not actively bleeding. [2] This recommendation distinguishes ACS from other hospitalized populations in which a 7 g/dL threshold is the default.

The MINT trial framework illustrates the competing strategies: the liberal arm received RBC transfusion sufficient to raise hemoglobin to at least 10 g/dL, whereas the restrictive arm permitted transfusion below 8 g/dL or for persistent angina despite medical therapy. [14] Thus, persistent angina despite medical therapy is a clinical escalation feature that can justify transfusion under a restrictive trial protocol even before hemoglobin falls below the lower threshold. [14]

The rationale for a higher hemoglobin target in acute MI is potential improvement in oxygen delivery to vulnerable myocardium; potential countervailing transfusion effects include increased blood viscosity, vascular inflammation, and reduced nitric oxide availability. [14] Because the AMI recommendation is conditional and low-certainty, incorporate ongoing ischemic symptoms and bleeding status into the decision rather than treating every hemoglobin value below 10 g/dL identically. [2][9][14]
- Hospitalized acute MI with hemoglobin <10 g/dL: consider a liberal transfusion strategy. [9]
- ACS with acute or chronic anemia and no active bleeding: maintaining hemoglobin at 10 g/dL may be reasonable. [2]
- Persistent angina despite medical therapy was an allowed transfusion indication in the restrictive MINT strategy. [14]
- Do not extrapolate the 2023 general 7 g/dL recommendation to AMI without applying the AMI-specific guidance. [9][23][24]

### Acute MI versus preexisting cardiovascular disease

Preexisting cardiovascular disease and acute MI should not be treated as interchangeable threshold categories. The 2023 AABB guideline permits use of an 8 g/dL threshold for patients with preexisting cardiovascular disease, whereas the AMI-specific AABB guideline suggests a liberal strategy below 10 g/dL. [9][23]

*Acute myocardial infarction uses a higher transfusion threshold than stable chronic cardiovascular disease. [2][9][23]*

| Clinical situation | Threshold approach | Decision modifier |
| --- | --- | --- |
| Acute MI with anemia | Liberal transfusion strategy when hemoglobin is <10 g/dL is suggested. [9] | Recommendation is conditional and low certainty. [9] |
| ACS with acute or chronic anemia, no active bleeding | Maintaining hemoglobin at 10 g/dL may be reasonable. [2] | Apply the ACS-specific recommendation rather than the general stable-adult threshold. [2][23] |
| Restrictive MINT-strategy patient | Transfusion permitted at <8 g/dL. [14] | Persistent angina despite medical therapy also permitted transfusion. [14] |
| Preexisting cardiovascular disease without acute MI | 8 g/dL may be selected. [23] | This category is not equivalent to acute MI. [9][23] |

## Use procedure-specific restrictive thresholds after cardiac or orthopedic surgery

Do not default to a liberal target solely because surgery occurred.

For patients undergoing cardiac surgery, the 2023 AABB guideline states that clinicians may choose a restrictive threshold of 7.5 g/dL. [23] Current cardiac-surgery guidance recommends restrictive strategies at hemoglobin 7.5 g/dL or lower rather than liberal strategies using thresholds of 9.0 to 9.5 g/dL. [7]

Randomized-trial syntheses support restrictive cardiac-surgery practice: among 8,645 cardiac-surgery patients in an updated review, a restrictive strategy of 7 to 8 g/dL was safe and reduced RBC use by 24%. [21] Trials comparing cardiac-surgery thresholds of approximately 7.5 g/dL versus 8 to 10 g/dL have generally shown few differences in adverse outcomes. [12]

For orthopedic surgery, the 2023 AABB guideline permits selecting an 8 g/dL threshold. [23] This is a population-specific restrictive threshold and should not be relabeled as a mandate to transfuse at 8 g/dL; use it as the threshold for considering transfusion within the operative and clinical context. [23][24]

Avoid assuming that more transfusion is benign after cardiac surgery. Observational data associate perioperative RBC transfusion with postoperative infection and ischemic morbidity, although such associations do not by themselves establish that transfusion caused the outcomes. [8]
- Cardiac surgery: select 7.5 g/dL when using the 2023 AABB restrictive threshold option. [23]
- Cardiac surgery: avoid routine liberal triggers of 9.0 to 9.5 g/dL when a restrictive strategy is appropriate. [7]
- Orthopedic surgery: 8 g/dL is an accepted restrictive threshold option. [23]
- Postoperative anemia alone does not establish a need for a liberal hemoglobin target. [7][21]

## Document why a patient does or does not fit the standard threshold

The threshold should be visible in the transfusion indication.

Before ordering RBCs, document the current hemoglobin and the threshold branch being used: less than 7 g/dL for the typical stable hospitalized adult, 7.5 g/dL for cardiac surgery, 8 g/dL for orthopedic surgery or preexisting cardiovascular disease, or the acute MI strategy centered on 10 g/dL. [2][9][23]

If the patient has active bleeding, the threshold-only framework is incomplete because the cited ACS recommendation for maintaining hemoglobin at 10 g/dL explicitly applies to patients who are not actively bleeding. [2] Shift the decision from a static hemoglobin trigger to the immediate clinical context and reassessment of bleeding and anemia.

Patients with chronic transfusion-dependent anemia or severe thrombocytopenia related to hematologic or oncologic treatment are not covered by the general AABB stable-adult threshold recommendation. [24] Avoid applying a one-size-fits-all 7 g/dL rule in these settings; use the disease-specific transfusion plan and bleeding-risk context.

Do not seek fresher RBC units solely because of storage duration. AABB recommends standard-issue RBCs selected at any point within the licensed dating period rather than limiting transfusion to units stored for less than 10 days. [24]
- State the selected threshold category in the transfusion order or progress note. [2][9][23]
- Active bleeding: do not use the nonbleeding ACS hemoglobin-10 recommendation as a stand-alone rule. [2]
- Chronic transfusion-dependent anemia and severe thrombocytopenia with hematologic or oncologic treatment: general adult threshold guidance does not apply. [24]
- Use standard-issue RBCs; do not require units less than 10 days old. [24]

## References
1. AABB Guideline for Blood Transfusion in Acute Myocardial Infarction | NEJM Clinician — clinician.nejm.org — https://clinician.nejm.org/aabb-guideline-blood-transfusion-acute-myocardial-infarction-nejm-jw.NA59106
2. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309
3. Red Blood Cell Transfusion: A Clinical Practice Guideline From the ... — www.acpjournals.org — https://www.acpjournals.org/doi/10.7326/0003-4819-157-1-201206190-00429
4. Impact of perioperative red blood cell transfusion on the prognosis of ... — www.cell.com — https://www.cell.com/heliyon/fulltext/S2405-8440(23)10289-1
5. Platelet Transfusion: A Clinical Practice Guideline From the AABB — www.acpjournals.org — https://www.acpjournals.org/doi/pdf/10.7326/M14-1589
6. Guideline: A hemoglobin threshold of 7 to 8 g/dL is ... - ACP Journals — www.acpjournals.org — https://www.acpjournals.org/doi/10.7326/ACPJC-2017-166-4-015
7. Perioperative Anemia and Patient Blood Management in Cardiac ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001446
8. Increased Mortality, Postoperative Morbidity, and Cost After Red ... — www.ahajournals.org — https://www.ahajournals.org/doi/pdf/10.1161/circulationaha.107.698977
9. Red Cell Transfusion in Acute Myocardial Infarction: AABB International Clinical Practice Guidelines — www.acpjournals.org — https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-25-00706?download=true
10. Critical Care Management of Patients After Cardiac Arrest — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001163
11. Red Blood Cell Transfusion : JAMA — journals.lww.com — https://journals.lww.com/00005407-202311210-00024
12. Transfusion of Amustaline/Glutathione... : Anesthesiology — journals.lww.com — https://journals.lww.com/anesthesiology/fulltext/2025/11000/transfusion_of_amustaline_glutathione.17.aspx
13. Restrictive versus liberal strategy for red... : Medicine — journals.lww.com — https://journals.lww.com/md-journal/_layouts/15/oaks.journals/downloadpdf.aspx?an=00005792-201908090-00069
14. Rationale and design for the myocardial ischemia... : American Heart Journal — journals.lww.com — https://journals.lww.com/00000406-202303000-00015
15. Transfusion‐related adverse events in patients with restrictive or ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/trf.70006
16. Early Haemoglobin response after single‐unit red blood ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/tme.70099
17. Transfusion‐related adverse events in patients with ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/trf.70006
18. Evaluation and management of anemia in the elderly — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/ajh.23598
19. Delirium Outcomes in a Randomized Trial of Blood Transfusion ... — agsjournals.onlinelibrary.wiley.com — https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.12396
20. American Burn Association Clinical Practice Guideline on ... — academic.oup.com — https://academic.oup.com/jbcr/article/46/6/1155/8213810
21. Clinical trials evaluating red blood cell transfusion thresholds: An updated systematic review and with additional focus on patients with cardiovascular disease - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0002870318301169
22. Counterpoint: the design and interpretation of blood transfusion randomized clinical trials - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S000649712501047X
23. Red Blood Cell Transfusion: 2023 AABB International Guidelines. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/37824153
24. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/27732721

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.